Heart Failure Study Proves Serial Testing of ST2 Can Help Improve Patient Care ... Business Wire (press release) Study shows ST2 accurately reflects a patient's changing condition, adding prognostic value over and above clinical variables plus NT-proBNP and high sensitive troponin. Evaluating Galectin-3 by BG Medicine (NASDAQ:BGMD) in the same study cohort ... |
